Other OTC Pharmaceuticals (Pharmacies) - Moldova

  • Moldova
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$7.29m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.54%, resulting in a market volume of US$7.87m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.19 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Moldova has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this development. Customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Moldova have been influenced by global and regional trends. Customers are increasingly seeking convenience and accessibility when it comes to purchasing over-the-counter medications. This has led to a rise in the popularity of pharmacies, as they offer a wide range of products and are easily accessible to consumers. Additionally, customers are becoming more health-conscious and are taking a proactive approach towards their well-being. As a result, they are more likely to purchase OTC medications to treat minor ailments and maintain their overall health. Trends in the market indicate that the Other OTC Pharmaceuticals (Pharmacies) market in Moldova is expanding due to several factors. One key trend is the increasing prevalence of self-medication. As consumers become more informed about their health and have access to a wide range of information online, they are more likely to self-diagnose and self-treat minor ailments. This has led to an increased demand for OTC medications, which can be easily obtained from pharmacies without a prescription. Another trend is the growing popularity of natural and herbal remedies. Consumers are increasingly seeking alternative treatments and are willing to try natural products for their health needs. This has led to a rise in the availability and sales of herbal and natural OTC medications in pharmacies. Local special circumstances also play a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Moldova. The country has a well-established healthcare system, with pharmacies playing a crucial role in providing accessible healthcare services to the population. Pharmacies in Moldova are regulated and monitored by the Ministry of Health, ensuring that they meet the required standards of quality and safety. Additionally, the presence of a large number of pharmacies in urban and rural areas makes OTC medications easily accessible to consumers across the country. Underlying macroeconomic factors contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Moldova. The country has experienced steady economic growth in recent years, which has resulted in an increase in disposable income and improved living standards. This has had a positive impact on the healthcare sector, as consumers are more willing to spend on their health and well-being. Furthermore, the government has implemented policies to support the development of the pharmaceutical industry, including the promotion of local production and the improvement of healthcare infrastructure. These factors have created a favorable environment for the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Moldova. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Moldova is developing due to customer preferences for convenience and accessibility, trends in self-medication and natural remedies, local special circumstances such as a well-established healthcare system and the presence of pharmacies, and underlying macroeconomic factors including economic growth and government support.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)